Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure

Potapov, Evgenij V.; Hennig, Felix; Wagner, Frank D.; Volk, Hans-Dieter; Sodian, Ralf; Hausmann, Harald; Lehmkuhl, Hans B.; Hetzer, Roland
May 2005
European Journal of Cardio-Thoracic Surgery;May2005, Vol. 27 Issue 5, p899
Academic Journal
Abstract: Objective: In patients with inotrope-dependent end-stage heart failure the timely application of the most suitable treatment, i.e. heart transplantation, implantation of a ventricular assist device or conservative treatment, is a key issue for therapeutic success. Methods: Seventy-six inotrope-dependent patients with end-stage heart failure were enrolled. Measurements of hemodynamics, routine laboratory parameters, and clinical examination were performed daily. Additionally, natriuretic peptides (BNP and NT-proBNP) and E-selectin were measured at the end of the study. The patients were retrospectively divided into groups with regard to the following end-points: Group I—deterioration into cardiogenic shock after an initially stable clinical course (n=26); Group II—stable clinical course without deterioration into cardiogenic (n=41); Group III—weaning from inotropic support (n=9). Results: One day before cardiogenic shock occurred, BNP, NT-proBNP and E-selectin were significantly elevated in group I compared with group II. A logistic regression model showed that only BNP and E-selectin were independent predictors of clinical deterioration on the following day. The odds ratio (OR) for E-selectin using a cut-off point of 65ng/ml was 8.7 and for BNP using a cut-off of 500pg/ml it was 4.8. In combination, the OR increased to 11.1. Continuous decrease of NT-proBNP predicted patients in whom weaning from inotropes was possible. Conclusions: While routine parameters did not predict the clinical course, elevated BNP and E-selectin independently predicted cardiogenic shock on admission and 1 day before its occurrence. The combination showed increased predictive value.


Related Articles

  • Effects of spironolactone on endothelial function converting enzyme activity, prognostic markers in patients with mild already taking optimal treatment function, vascular and other heart failure. Macdonald, J. E.; Kennedy, N.; A. D. Struthers // Heart;Jul2004, Vol. 90 Issue 7, p765 

    Objectives: To examine whether the favourable effects on endothelial function, vascular angiotensin converting enzyme (ACE) activity, cardiac remodelling, autonomic function, and QT intervals of spironolactone in combination with ACE inhibitor also occur in patients with New York Heart...

  • Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Parissis, J. I.; Adamopoulos, S.; Farmakis, D.; Filippatos, G.; Paraskevaidis, I.; Panou, F.; Iliodromitis, E.; D. Tb Kremastinos // Heart;Dec2006, Vol. 92 Issue 12, p1768 

    Background: Levosimendan is a novel inodilator that improves central haemodynamics and symptoms of patients with decompensated chronic heart failure. The role, however, of repeated levosimendan infusions in the management of these patients has not yet been properly assessed. Purpose: This...

  • Healing after myocardial infarction. Ertl, Georg; Frantz, Stefan // Cardiovascular Research;Apr2005, Vol. 66 Issue 1, p22 

    Abstract: Wounding and healing are archaic principles, prerequisite for survival of any biologic material. However, strategies to cope with wounding may be quite different among organisms, species, or among various organs of one species. Today, myocardial infarction and the consequent loss of...

  • First experiences with a novel magnetically suspended axial flow left ventricular assist device. Hetzer, Roland; Weng, Yuguo; Potapov, Evgenij V.; Pasic, Miralem; Drews, Thorsten; Jurmann, Michael; Hennig, Ewald; Müller, Johannes // European Journal of Cardio-Thoracic Surgery;Jun2004, Vol. 25 Issue 6, p964 

    Axial flow pumps have gained increased acceptance since their first clinical use in 1998. The present report summarizes the clinical experience with patients treated for severe cardiogenic shock for the first time with a newly developed axial flow pump with magnetically levitated bearings....

  • Androgen Deprivation Therapy and Cardiovascular Risk. Mourmouris, Panagiotis; Efstathiou, Eleni; Papatsoris, Athanasios // Nephro-Urology Monthly;Jan2013, Vol. 5 Issue 1, p653 

    The article discusses the concerns raised regarding the cardiovascular side effects of androgen deprivation therapy (ADT) and their impact on the survival of elderly patients with prostate cancer. It states that several studies show heart failure, acute myocardial infarction, and coronary heart...

  • Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Li, Yiwen; Takemura, Genzou; Okada, Hideshi; Miyata, Shusaku; Maruyama, Rumi; Li, Longhu; Higuchi, Masato; Minatoguchi, Shinya; Fujiwara, Takako; Fujiwara, Hisayoshi // Cardiovascular Research;Sep2006, Vol. 71 Issue 4, p684 

    Abstract: Objectives: Late treatment with erythropoietin (EPO), as well as the administration before the onset of or during the acute stage of myocardial infarction (MI), has recently been shown to mitigate post-MI heart failure. We investigated the mechanisms, including the downstream signaling...

  • Differential prognostic importance of QRS duration in heart failure and acute myocardial infarction associated with left ventricular dysfunction. Fosbøl, Emil Loldrup; Seibæk, Marie; Brendorp, Bente; Møller, Daniél Vega; Ersbøll, Mads; Torp-Pedersen, Christian; Køber, Lars // European Journal of Heart Failure;Aug2007, Vol. 9 Issue 8, p814 

    Abstract: Background/Aims: Studies of the prognostic importance of QRS duration in patients with heart failure (HF) have shown conflicting results and few studies have estimated the importance after myocardial infarction (MI). Methods: The Danish Investigations and Arrhythmia ON Dofetilide...

  • your heart.  // Good Health (Australia Edition);May2010, p89 

    The article details the working of heart, focusing on several heart diseases and presents suggestions on how to prevent them. It is mentioned that a major cause of disability and the most common cause of death in Australia is coronary heart disease. It is suggested to take prescribed medicines...

  • Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Capewell, S.; Unal, B.; Critchley, J. A.; McMurray, J. J. V. // Heart;Apr2006, Vol. 92 Issue 4, p521 

    The article examines the reduction in coronary heart disease (CHD) deaths that are potentially achievable through increasing treatment levels in Great Britain. In line with the effort to increase treatment uptakes, the 2003 general medical services contract will now reward the identification of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics